1-Cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea ; CAS # 29094-61-9 ;

Glipizide BP Impurity A ; [2-(4-Sulphamoylphenyl) ethyl] 5-methyl-pyrazine-2-carboxamide ; CAS # 33288-71-0 ;

Glipizide BP Impurity B ; Cyclohexylamine HBr ; CAS # 108-91-8 (base) ; 4998-76-9 (HCl salt) ; 26227-54-3 (HBr salt) ;

Glipizide BP Impurity C ; Ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate ; CAS # 13554-93-3 ;

Glipizide BP Impurity D ; 6-Methyl-N-[2-(4-sulfamoylphenyl)-ethyl]pyrazine-2-carboxamide ; CAS # 1346600-54-1 ;

Glipizide BP Impurity E ; 5-Desmethyl-6-Methyl Glipizide ; Glipizide 6-Methyl Analog ; CAS # 66375-96-0 ;

Glipizide BP Impurity F ; [2-[4-(Aminosulfonyl)phenyl]ethyl]carbamic acid ethyl ester ; CAS # 192118-08-4 ;

Glipizide BP Impurity G ; Methyl 4-[β-(5-Methylpyrazine-2-carboxamido)ethyl]benzene sulfonamide carbamate ; CAS # 33288-74-3 ;

Glipizide BP Impurity H ; 1-Cyclohexyl-3-(p-sulfamoylphenethyl)urea ; CAS # 10080-05-4 ;

Glipizide BP Impurity I ; N1-[4-(β-Cyclohexylureidoethyl)benzensulfonyl] N3-cyclohexylurea ; CAS # 10079-35-3 ;